(UroToday.com) The utilization of multiparametric magnetic resonance imaging (mpMRI) in the diagnosis and management of prostate cancer has rapidly expanded in the past few years. The recent PRECISION trial, along with others, have examined the value of mpMRI prior to prostate biopsy in men with elevated PSA levels. In general, these studies have demonstrated a decrease in the detection of low-grade prostate cancer along with concomitant increase in the diagnosis of high-grade prostate cancer for men undergoing MRI prior to biopsy. This has been interpreted widely as supporting the role of MRI.